About SigTuple Technologies Pvt.
SigTuple Technologies is a medical technology company that develops AI-powered automated digital microscopy solutions for pathology and laboratory diagnostics. Founded nearly two decades ago after co-founder and CEO Tathagato Rai Dastidar lost his father to misdiagnosis of acute myeloid leukaemia, the company has built a comprehensive platform combining artificial intelligence, robotics, microfluidics, and high-resolution microscopy to automate microscopic analysis of biological samples. With over 10 years of R&D, 27 patents, and 30+ publications, SigTuple has deployed 350+ systems across 7 countries. The company offers three purpose-built platforms: the AS76 (CE-IVDR compliant edge AI digital morphology analyser for peripheral blood smears with true 100X oil immersion), the AI100 (FDA and CE cleared multi-purpose analyser for both peripheral blood smear and urine sediment), and SigVet (point-of-care platform for veterinary clinics). Their technology enables automated cell morphology analysis with pathologist-grade accuracy across 30+ cell types, delivering results in under a minute while maintaining complete data privacy through on-device AI inference. SigTuple serves medium to large laboratories, small to medium laboratories, and veterinary clinics, with particular impact in rural and underserved healthcare settings across India and globally. The company has partnered with major healthcare organizations including Krsnaa Diagnostics, HCG hospitals, and HORIBA, and has been recognized as one of the top 100 health tech companies in South Asia.
Mission & Story
Founding Story
Founded after co-founder and CEO Tathagato Rai Dastidar lost his father almost two decades ago to misdiagnosis of acute myeloid leukaemia. This led him to quit his job and start SigTuple to address diagnostic accuracy challenges.
Clinical Focus
Medical conditions and clinical areas addressed by SigTuple Technologies Pvt..
Who It Serves
Milestones & Awards
Recent Milestones
U.S. FDA approval for AI100 blood smear application with Shonit, HORIBA partnership adding AI100 to their portfolio, HCG hospitals adoption of AI100, 350+ deployments across 7 countries, recognized as top 100 health tech company in South Asia
Awards & Recognition
Health Tech 100 (top 100 health tech companies in South Asia), featured at RAISE 2020, WIPO recognition for digital microscopy innovation
Key Partnerships
Company Details
- Headquarters
- Bengaluru, Karnataka, India
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.